NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 262 filers reported holding NEKTAR THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $153,000 | +4.1% | 256,385 | 0.0% | 0.00% | – |
| Q2 2023 | $147,000 | -18.3% | 256,385 | 0.0% | 0.00% | – |
| Q1 2023 | $180,000 | -68.9% | 256,385 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $579,000 | -31.2% | 256,385 | -1.0% | 0.00% | 0.0% |
| Q3 2022 | $841,000 | -15.8% | 258,941 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $999,000 | -29.5% | 262,849 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,417,000 | -60.4% | 262,849 | -0.8% | 0.00% | -66.7% |
| Q4 2021 | $3,579,000 | -24.8% | 264,943 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $4,759,000 | +3.6% | 264,943 | -1.0% | 0.00% | 0.0% |
| Q2 2021 | $4,593,000 | -13.0% | 267,604 | +1.4% | 0.00% | -42.9% |
| Q1 2021 | $5,279,000 | +16.8% | 263,949 | -0.7% | 0.01% | 0.0% |
| Q4 2020 | $4,519,000 | +2.5% | 265,802 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $4,409,000 | -28.2% | 265,802 | +0.3% | 0.01% | -36.4% |
| Q2 2020 | $6,139,000 | +30.3% | 265,102 | +0.4% | 0.01% | +10.0% |
| Q1 2020 | $4,712,000 | +26.5% | 263,985 | +52.9% | 0.01% | +100.0% |
| Q4 2019 | $3,726,000 | +20.1% | 172,600 | +1.3% | 0.01% | 0.0% |
| Q3 2019 | $3,103,000 | -82.9% | 170,400 | -66.7% | 0.01% | -50.0% |
| Q2 2019 | $18,189,000 | +225.9% | 511,200 | +207.8% | 0.01% | 0.0% |
| Q1 2019 | $5,581,000 | +2.2% | 166,100 | 0.0% | 0.01% | -9.1% |
| Q4 2018 | $5,460,000 | -46.4% | 166,100 | -0.5% | 0.01% | -35.3% |
| Q3 2018 | $10,180,000 | +26.3% | 167,000 | +1.2% | 0.02% | +21.4% |
| Q2 2018 | $8,057,000 | +389.8% | 165,000 | +966.0% | 0.01% | +366.7% |
| Q1 2018 | $1,645,000 | -16.4% | 15,478 | -53.0% | 0.00% | 0.0% |
| Q4 2017 | $1,968,000 | +9.3% | 32,946 | -78.9% | 0.00% | -25.0% |
| Q2 2013 | $1,801,000 | – | 155,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |